News
Zacks Investment Research on MSN1d
Beam Therapeutics to Report Q1 Earnings: What's in the Cards?We expect investors to focus on Beam Therapeutics’ BEAM progress in developing its pipeline candidates, which are being ...
Q4 2024 Earnings Call Transcript April 11, 2025 Beam Global misses on earnings expectations. Reported EPS is $-0.31 EPS, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback